Search - tctmd.com

Displaying 81 - 100 of 403

Sort: Relevancy | Date

News Daily News

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

L.A. McKeown

May 15, 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

Caitlin E. Cox

April 22, 2024

News Daily News

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Yael L. Maxwell

April 18, 2024

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Daily News

Cognitive Impairment a Real Concern in HF Patients: HFSA

Caitlin E. Cox

March 13, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT Abstracts 2024

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Presenter: Eduardo Arias

March 05, 2024

Presentation THT Abstracts 2024

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Presenter: Jennifer Cowger

March 05, 2024

Presentation THT Abstracts 2024

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Presenter: John Eisenga

March 05, 2024

Presentation THT 2024

Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study

Presenter: Palak Shah

March 05, 2024

Presentation THT 2024

Initial Experience with Transcatheter Myotomy (SESAME) to Treat Hypertrophic Cardiomyopathy and Left Ventricular Outflow Obstruction

Presenter: Adam B. Greenbaum

March 05, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Advertisement

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Cognitive Impairment a Real Concern in HF Patients: HFSA

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Center variability in patient management may influence incidence of infection during durable left ventricular assist device support 2013 an analysis from the ASPIRE Survey and STS Intermacs

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study

Initial Experience with Transcatheter Myotomy (SESAME) to Treat Hypertrophic Cardiomyopathy and Left Ventricular Outflow Obstruction

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content